Menu

Consolidated Income Statement

35.5 KB EXCEL
€ million Note 2016 2015
Net sales ➞ 7 15,024 12,845
Cost of sales ➞ 8 – 5,201 – 4,076
(of which: amortization of intangible assets)1 (– 181) (– 167)
Gross profit 9,823 8,768
       
Marketing and selling expenses ➞ 9 – 4,526 – 4,050
(of which: amortization of intangible assets)1 (– 1,032) (– 779)
Administration expenses – 854 – 720
Research and development costs ➞ 10 – 1,976 – 1,709
(of which: amortization of intangible assets)1 (– 4) (– 3)
Other operating income ➞ 11 996 471
Other operating expenses ➞ 12 – 981 – 917
Operating result (EBIT) 2,481 1,843
       
Financial result ➞ 13 – 326 – 357
Profit before income tax 2,154 1,487
       
Income tax ➞ 14 – 521 – 368
Profit after tax from continuing operations 1,633 1,118
Profit after tax from discontinued operations 6
Profit after tax 1,633 1,124
       
of which: attributable to Merck KGaA shareholders (net income) 1,629 1,115
of which: attributable to non-controlling interests ➞ 24 4 9
       
Earnings per share (in €) ➞ 15
basic 3.75 2.56
– thereof: from continuing operations 3.75 2.55
– thereof: from discontinued operations 0.01
       
diluted 3.75 2.56
– thereof: from continuing operations 3.75 2.55
– thereof: from discontinued operations 0.01
1
Excluding amortization of internally generated or separately acquired software.